NCT00457314

Brief Summary

Mitochondrial myopathies include various inherited diseases that are caused by damage to the mitochondria, energy-producing structures that fuel the body's processes. The main symptoms are muscle weakness, reduced muscle mass, and difficulty with exercising. The purpose of this study is to determine the effects of exercise training versus inactivity on mitochondrial function in muscle and muscle performance in people with mitochondrial myopathies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jun 2007

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 6, 2007

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2007

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

May 19, 2009

Status Verified

May 1, 2009

Enrollment Period

5 years

First QC Date

April 5, 2007

Last Update Submit

May 18, 2009

Conditions

Keywords

single-large scale deletionspoint mutations in mtDNA

Outcome Measures

Primary Outcomes (2)

  • Changes in wild-type (normal), mutant, and total mitochondrial DNA copy number

    Measured at Week 26

  • Physiological measure of oxidative metabolism

    Measured at Week 26

Study Arms (2)

1

EXPERIMENTAL

Participants will partake in regular exercise training for 6 months. After 6 months, they will switch to no exercise training for 6 months. Participants will then be encouraged to continue exercise training for an additional 1 year.

Behavioral: Exercise

2

EXPERIMENTAL

Participants will not partake in regular exercise training for 6 months. After 6 months, they will switch to exercise training for 6 months. Participants will then be encouraged to continue exercise training for an additional 1 year.

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

Regular exercise training

12

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of mitochondrial myopathy
  • Single-large scale deletions of mitochondrial DNA
  • Point mutations in mitochondrial DNA

You may not qualify if:

  • Symptoms or electrocardiogram-generated signs of coronary artery disease
  • Symptoms of congestive heart failure; peripheral vascular disease; or lung, kidney, or liver disease
  • History of alcohol or substance abuse
  • Metal implants or related devices that contraindicate MRI
  • Current use of or require any medications that have significant systemic cardiovascular effects
  • Diabetes
  • Obesity (body mass index \[BMI\] greater than 30)
  • Resting systolic blood pressure greater than 140 mmHg and/or diastolic blood pressure greater than 90 mmHg at three different times

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas Southwestern Medical Center

Dallas, Texas, 75321, United States

RECRUITING

MeSH Terms

Conditions

Mitochondrial Myopathies

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesMitochondrial DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Ronald Haller, MD

    University of Texas Southwestern Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
NIH

Study Record Dates

First Submitted

April 5, 2007

First Posted

April 6, 2007

Study Start

June 1, 2007

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

May 19, 2009

Record last verified: 2009-05

Locations